The iCARE Rapid Anti-HIV 1 and 2 Test is a rapid HIV antibody test that is used to check for the presence of HIV antibodies and free HIV-1 p24 antigen. It has been evaluated for its sensitivity and specificity for both HIV-1 antibodies and free HIV-1 p24 antiglycans. The test is available for use in clinics and medical laboratories worldwide.
Detection of HIV-1/2 Antibodies
The iCARE Rapid Anti-HIV 1 & 2 Test is a rapid screening test for HIV. It detects HIV-1/2 antibodies in oral swabs by chromatographic immunoassay. The test uses colloidal gold reagents labelled with specific HIV-1/2 antigens. Positive results show two distinct pink coloured bands. Negative results show only one pink coloured band, indicating the absence of HIV-1/2 antibodies.
HIV testing is critical for people who were infected in West Africa, or who have contact with people with links to the region. The rapid oral HIV test can detect HIV-1 and HIV-2 antibodies in three to six months after infection. In addition, the American Red Cross uses this test to screen people donating blood. The rapid tests are accurate and sensitive enough to detect antibodies in about 80 percent of people.
Detection of Free HIV-1 p24 Antigen
The iCARE Rapid Anti-HIV 1 and 2 Test detects free HIV-1 p24 polypeptide (p24) antigen. Its sensitivity is greater than other HIV antigen tests. The result can indicate HIV infection much earlier than with antibody-only tests.
The rapid HIV tests detect p24Ag in distinct variants. The RST detected 36/50 samples, while STAT-VIEW detected only 26/50 samples. The new 4G Alere HIV test detects HIV-1 p24 antigen in more than four times as many samples as the RST. It is more sensitive than the other RSTs and can detect six additional samples in addition to the ones tested. Additionally, the new 4G Alere test allows for detection of HIV-1 p24 antigen in more complex strains of HIV-1.
Availability
The iCARE Rapid Anti-HIV 1 and 2 Test is an oral rapid screening test for HIV infection. The test detects HIV-1/2 antibodies from oral swabs. It is 99% accurate and gives results in 10 minutes. The HIV virus attacks the immune system and can cause AIDS, the most severe stage of HIV disease. Thousands of satisfied customers around the world have used the iCARE Test.
The iCARE Rapid Anti-HIV 1 & 2 Test is an immunochromatographic, qualitative detection test that screens for antibodies to HIV-1 and HIV-2. The test is available in two formats, hospital-based and home-based. The test uses a simple, one-step process to determine HIV infection.
The iCARE Rapid Anti-HIV 1 and 2 Test stands as a revolutionary advancement in HIV screening, ensuring 99% accuracy and delivering results within 10 minutes. This HIV 1&2 4th Generation Test, commonly referred to as the Fourth Generation HIV Test or HIV Combo Test, is a game-changer in early detection. It combines the efficacy of HIV 1&2 Antigen/Antibody testing and includes the vital HIV P24 Antigen Test. This test not only ensures early diagnosis but also provides a crucial HIV 4th Gen Test Window Period, detecting HIV at the earliest stages.
Our HIV 4th Gen Testing Procedure is swift and reliable, utilizing HIV 1&2 RNA PCR Test technology to enhance sensitivity. With our Fast HIV Test Results, the anxiety of waiting is diminished. Worried about “HIV Test Near Me”? Rest assured, our services are accessible locally. We offer Confidential HIV Testing in a supportive environment, coupled with HIV Testing and Counselling services, ensuring individuals receive the support they need during this crucial time.
Moreover, we understand the importance of affordability. That’s why we provide an Affordable HIV Combo Test, ensuring economic access to this vital healthcare service. Wondering “Where to Get HIV 4th Gen Testing?” Look no further; our services are designed to empower individuals, combining accuracy, speed, confidentiality, and affordability. Take control of your health; opt for the iCARE Test – where precision meets compassion.